Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$39,371,139
+$8,497,330 QoQ
Shares Held
1,955,844
+2.3% QoQ
Ownership
3.67%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 11.18852014782365.ToString("F0")%
Shared 0.ToString("F0")%
None 88.81147985217635.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. KALV ranks #108 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,371,139 | 1,955,844 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,873,809 | 1,911,691 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $19,189,541 | 1,575,496 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,256,538 | 1,349,539 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,620,640 | 1,093,643 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,780,609 | 1,390,863 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,725,232 | 1,271,609 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,910,745 | 756,430 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,046,891 | 594,173 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,579,499 | 537,102 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,423,501 | 459,346 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,015,575 | 446,175 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,295,391 | 419,261 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,730,769 | 403,960 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $6,120,593 | 421,819 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $4,036,879 | 410,252 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $13,838,899 | 938,867 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,917,642 | 1,051,976 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,214,798 | 1,043,828 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,556,003 | 1,400,501 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $15,194,915 | 591,472 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $5,082,749 | 267,654 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,280,513 | 260,565 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $3,046,417 | 251,770 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,874,257 | 245,001 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||